This document contains information on how to complete the Cell Therapy MED-A data collection form.
This manual explains how to complete the EBMT Cell Therapy MED-A form, which collects data on cell therapies including T-lymphocytes, CAR-T cells, and other advanced therapies. It covers registration timing, patient follow-up, and form submission requirements.
The form is divided into sections for Day 0 registration, Day 100 follow-up, and combined 6-month/annual follow-up. It applies to centers performing cell therapy, not referral or follow-up-only centers. Forms must be submitted as close to the treatment date as possible, with specific rules for multiple infusions or changes in indication.
The Day 0 registration form should be submitted as close to the date of cell therapy as possible. Remaining forms should be recorded at their specific timepoints (at day 100, 6 months, 1 year after the cell therapy and then annually) or at time of death, whichever occurs first.
For therapy with cell infusions distributed across several days, overall lasting more than 100 days and given for the same indication, submit one form per 100-day interval, starting with the first infusion episode within each interval.
The form covers stem cells, progenitors or mature cells, such as T-lymphocytes, sorted, cultured and/or genetically manipulated, whether hematopoietic or non-hematopoietic, including CAR-T cells and other advanced therapeutic medicinal products (ATMP).